Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

NCT: NCT05818098 · COMPLETED

NCT IDNCT05818098
StatusCOMPLETED
Start Date2023-03-29
Completion2023-09-15
SponsorShanghai MicroPort Rhythm MedTech Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective and multicenter clinical investigation aiming to evaluate the safety and effectiveness of coronary intravascular lithotripsy system for the treatment of patients with coronary calcification.

Frequently Asked Questions

What is Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)?

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR) is a clinical trial registered under NCT05818098. Current status: COMPLETED.

What is the status of NCT05818098?

The current status of NCT05818098 (Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)) is: COMPLETED.

When did Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR) start?

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR) started on 2023-03-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑